The recently enacted Section 456.0301, F.S., requires the Board to approve continuing education courses for those physicians who prescribe controlled substances. The proposed rule amendments set forth the entities approved by the Board to provide ...

 

DEPARTMENT OF HEALTH

Board of Medicine

RULE NOS.:RULE TITLES:

64B8-13.005Continuing Education for Biennial Renewal

64B8-13.008Requirement for Continuing Education Course on Prescribing Controlled Substances

PURPOSE AND EFFECT: The recently enacted Section 456.0301, F.S., requires the Board to approve continuing education courses for those physicians who prescribe controlled substances. The proposed rule amendments set forth the entities approved by the Board to provide the prescribing controlled substances course for licensure renewal and add additional entities to the recent new rule requiring the course for prescribers prior to January 31, 2019.

SUBJECT AREA TO BE ADDRESSED: Approval of entities for controlled substance prescribing course.

RULEMAKING AUTHORITY: 456.0301(2) FS.

LAW IMPLEMENTED: 456.0301 FS.

IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Claudia Kemp, Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253.

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.